AI English summary of an SEC filing — figures as filed
Cadence said on November 17, 2025 its board of directors appointed Dr. Luc Van den hove as a director, effective January 1, 2026. The company said the committee assignment has not yet been determined.
Key points
AI summaryCadence said on November 17, 2025 its board of directors appointed Dr. Luc Van den hove as a director, effective January 1, 2026. The company said the committee assignment has not yet been determined.
Cadence said Dr. Van den hove will be granted equity under the 1995 Directors Stock Incentive Plan with a grant date fair value of $82,849, subject to approval by the Compensation Committee.
The company said the equity award will fully vest on the earlier of May 8, 2026 and the date of Cadence's annual meeting of stockholders in 2026, subject to Dr. Van den hove's continued service on the board. It said his cash compensation will be generally consistent with that of Cadence's other non-employee directors and that he will enter into Cadence's standard form of indemnification agreement.
Cadence said Dr. Van den hove has been with imec since its founding in 1984 and has served as president and chief executive officer since 2009. He will continue in that role through March 31, 2026, then transition to chair of imec's board of directors on April 1, 2026.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Dr. Luc Van den hove Appointed to Board of Directors, Effective January 1, 2026
Cadence said on November 17, 2025 its board of directors appointed Dr. Luc Van den hove as a director, effective January 1, 2026. The company said the committee assignment has not yet been determined.
Source · Based on the filing body and exhibits
Equity Award Granted Under 1995 Directors Stock Incentive Plan
Cadence said Dr. Van den hove will be granted equity under the 1995 Directors Stock Incentive Plan with a grant date fair value of $82,849, subject to approval by the Compensation Committee.
Source · Based on the filing body and exhibits
Equity Award Vesting Terms, Cash Compensation and Indemnification Agreement
The company said the equity award will fully vest on the earlier of May 8, 2026 and the date of Cadence's annual meeting of stockholders in 2026, subject to Dr. Van den hove's continued service on the board. It said his cash compensation will be generally consistent with that of Cadence's other non-employee directors and that he will enter into Cadence's standard form of indemnification agreement.
Source · Based on the filing body and exhibits
imec Career and Transition to Chair of imec Board of Directors on April 1, 2026
Cadence said Dr. Van den hove has been with imec since its founding in 1984 and has served as president and chief executive officer since 2009. He will continue in that role through March 31, 2026, then transition to chair of imec's board of directors on April 1, 2026.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…